Literature DB >> 19917287

Stem cells in the pituitary gland: A burgeoning field.

Hugo Vankelecom1, Lies Gremeaux.   

Abstract

The pituitary gland represents the endocrine core of the organism, and is well-known for its cellular plasticity in order to meet the body's fluctuating hormonal demands. In the past, it has repeatedly been postulated that the pituitary harbors tissue-specific stem cells that participate in the generation of new endocrine cells during this dynamic cell remodeling, as well as during the slow but robust homeostatic turnover of the gland. However, their presence and identity remained elusive until this conundrum recently attracted renewed interest. Our discovery of a 'side population' using flow cytometry was the first step towards a more convincing candidate stem/progenitor cell population in the endocrine anterior pituitary. Since then, several other groups have endeavored to search for pituitary stem/progenitor cells, which finally culminated in the identification of very strong candidates. Multiple markers were put forward, among which the pluripotency transcription factor Sox2 occupies center stage. Now that very plausible pituitary stem/progenitor cells can be isolated and assayed, detailed characterization of their involvement in pituitary cell remodeling during basal renewal, dynamic adaptation and potential response to injury is around the corner, and is expected to significantly advance our knowledge on pituitary biology. In addition, a comprehensive study of the stem/progenitor cells may guide us to a better understanding of pituitary hormonal deficiencies, as well as of pituitary tumorigenesis in which 'cancer stem cells' may play a central role. Nevertheless, many questions remain to be resolved, and future challenges are huge. In this review, we provide a detailed overview of the exciting recent developments in the pituitary stem cell quest. In addition we pinpoint some discordant findings and include a number of cautionary and critical reflections. The recent acceleration in pituitary stem cell research may initiate a very exciting era in the pituitary field. May we say that "La nouvelle hypofyse est arrivée"? Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19917287     DOI: 10.1016/j.ygcen.2009.11.007

Source DB:  PubMed          Journal:  Gen Comp Endocrinol        ISSN: 0016-6480            Impact factor:   2.822


  23 in total

Review 1.  Pituitary stem cell update and potential implications for treating hypopituitarism.

Authors:  Frederic Castinetti; Shannon W Davis; Thierry Brue; Sally A Camper
Journal:  Endocr Rev       Date:  2011-04-14       Impact factor: 19.871

Review 2.  Stem cells and cancer stem-like cells in endocrine tissues.

Authors:  Ricardo V Lloyd; Heather Hardin; Celina Montemayor-Garcia; Fabio Rotondo; Luis V Syro; Eva Horvath; Kalman Kovacs
Journal:  Endocr Pathol       Date:  2013-03       Impact factor: 3.943

3.  Decreased TAp63 and ΔNp63 mRNA Levels in Most Human Pituitary Adenomas Are Correlated with Notch3/Jagged1 Relative Expression.

Authors:  Lisiane Cervieri Mezzomo; Frederico Giacomoni Pesce; Josenel Maria Barcelos Marçal; Taiana Haag; Nelson Pires Ferreira; Julia Fernanda Semmelmann Pereira Lima; Carolina Garcia Soares Leães; Miriam Costa Oliveira; Maria Beatriz da Fonte Kohek
Journal:  Endocr Pathol       Date:  2017-03       Impact factor: 3.943

4.  The Local Control of the Pituitary by Activin Signaling and Modulation.

Authors:  Louise M Bilezikjian; Wylie W Vale
Journal:  Open Neuroendocrinol J       Date:  2011-01-01

5.  Clinical, pathologic, and imaging characteristics of pituitary null cell adenomas as defined according to the 2017 World Health Organization criteria: a case series from two pituitary centers.

Authors:  Joao Paulo Almeida; Corbin C Stephens; Jennifer M Eschbacher; Michelle M Felicella; Kevin C J Yuen; William L White; Michael A Mooney; Anne Laure Bernat; Ozgur Mete; Gelareh Zadeh; Fred Gentili; Andrew S Little
Journal:  Pituitary       Date:  2019-10       Impact factor: 4.107

6.  Numb deletion in POMC-expressing cells impairs pituitary intermediate lobe cell adhesion, progenitor cell localization, and neuro-intermediate lobe boundary formation.

Authors:  Tyler B Moran; Leah B Goldberg; Sarah L Serviss; Lori T Raetzman
Journal:  Mol Endocrinol       Date:  2010-11-17

Review 7.  New insights into the role and origin of pituitary S100β-positive cells.

Authors:  Yukio Kato; Saishu Yoshida; Takako Kato
Journal:  Cell Tissue Res       Date:  2021-09-22       Impact factor: 5.249

8.  THE EXPRESSION OF STEM CELL MARKERS (CD133, NESTIN, OCT4, SOX2) IN INVASIVE PITUITARY ADENOMAS.

Authors:  R Basaran; D Gundogan; M Senol; C Bozdogan; F Gezen; A Sav
Journal:  Acta Endocrinol (Buchar)       Date:  2020 Jul-Sep       Impact factor: 0.877

9.  Significant quantitative and qualitative transition in pituitary stem /  progenitor cells occurs during the postnatal development of the rat anterior pituitary.

Authors:  S Yoshida; T Kato; H Yako; T Susa; L-Y Cai; M Osuna; K Inoue; Y Kato
Journal:  J Neuroendocrinol       Date:  2011-10       Impact factor: 3.627

10.  Generation of immortal cell lines from the adult pituitary: role of cAMP on differentiation of SOX2-expressing progenitor cells to mature gonadotropes.

Authors:  Ginah L Kim; Xiaomei Wang; Jennifer A Chalmers; David R Thompson; Sandeep S Dhillon; Margaret M Koletar; Denise D Belsham
Journal:  PLoS One       Date:  2011-11-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.